North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China · Delayed Price · Currency is CNY
5.53
0.00 (0.00%)
At close: Feb 24, 2026

SHA:600812 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9,4888,8709,78010,98120,45216,781
Market Cap Growth
3.95%-9.30%-10.94%-46.31%21.87%4.57%
Enterprise Value
20,18819,92620,59820,89530,11625,631
Last Close Price
5.535.155.666.3611.7310.10
PE Ratio
52.1969.851999.79-1092.06172.42
Forward PE
-40.5340.5340.5340.5340.53
PS Ratio
0.970.900.971.051.971.46
PB Ratio
1.421.331.561.762.912.38
P/TBV Ratio
3.573.372.933.014.323.44
P/FCF Ratio
63.1419.9224.3724.1440.68-
P/OCF Ratio
11.407.219.5510.9319.4722.31
EV/Sales Ratio
2.062.022.041.992.902.23
EV/EBITDA Ratio
13.1213.6416.1515.5124.6021.04
EV/EBIT Ratio
31.4029.6138.4032.9250.1842.87
EV/FCF Ratio
134.3444.7451.3445.9459.90-
Debt / Equity Ratio
1.671.721.781.771.961.62
Debt / EBITDA Ratio
7.247.477.887.8110.579.40
Debt / FCF Ratio
74.1125.7127.7824.2927.40-
Net Debt / Equity Ratio
1.431.471.621.501.210.93
Net Debt / EBITDA Ratio
6.496.707.976.956.925.37
Net Debt / FCF Ratio
63.4321.9825.3220.5916.85-25.66
Asset Turnover
0.450.470.480.460.430.54
Inventory Turnover
2.872.632.692.872.763.17
Quick Ratio
0.470.500.490.490.700.80
Current Ratio
0.670.750.780.720.891.03
Return on Equity (ROE)
4.22%3.32%0.79%-10.25%0.50%1.63%
Return on Assets (ROA)
1.86%1.98%1.59%1.72%1.54%1.74%
Return on Invested Capital (ROIC)
2.99%2.84%1.04%4.08%1.08%2.44%
Return on Capital Employed (ROCE)
7.00%6.40%5.00%7.20%5.60%4.90%
Earnings Yield
1.93%1.43%0.05%-6.28%0.09%0.58%
FCF Yield
1.58%5.02%4.10%4.14%2.46%-1.52%
Dividend Yield
0.55%0.58%0.18%-0.51%0.30%
Payout Ratio
241.49%369.37%10195.21%-3987.68%674.90%
Buyback Yield / Dilution
-7.99%-5.27%4.92%-0.70%-4.96%0.12%
Total Shareholder Return
-7.44%-4.69%5.10%-0.70%-4.45%0.42%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.